AI Article Synopsis
- Percutaneous coronary intervention (PCI) is a common medical procedure used to treat heart problems, but it may not work as well for people with chronic kidney disease (CKD).
- Many people have both heart disease and CKD, and this number is expected to grow, making it important to plan carefully for their treatment.
- To help these patients, doctors should prepare well before the procedure, use less contrast material during it, and give special medicines afterward to reduce their risk of serious issues.
Article Abstract
Percutaneous coronary intervention (PCI) is one of the most common procedures performed in medicine. However, its net benefit among patients with chronic kidney disease (CKD) is less well established than in the general population. The prevalence of patients suffering from both CAD and CKD is high, and is likely to increase in the coming years. Planning the adequate management of this group of patients is crucial to improve their outcome after PCI. This starts with proper preparation before the procedure, the use of all available means to reduce contrast during the procedure, and the implementation of modern strategies such as radial access and drug-eluting stents. At the end of the procedure, personalized antithrombotic therapy for the patient's specific characteristics is advisable to account for the elevated ischemic and bleeding risk of these patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100167 | PMC |
| http://dx.doi.org/10.3390/jcm11092380 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!